Deutsche Bank
CARL

Deutsche Bank’s Carlsmed CARL Stock Holding History

Deutsche Bank’s Portfolio CARL Stock Details CARL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$106K Buy
10,180
+348
+4% +$3.66K ﹤0.01% 3469
2026
Q1 		$89K Hold
9,832
– – ﹤0.01% 3317
2025
Q4 		$121K Buy
+9,832
New +$131K ﹤0.01% 3232

Other funds holding CARL

JT
Jupiter Topco New York $245B AUM
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KC
KCM Capital Shawnee, Kansas $618M AUM
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PWM
Palumbo Wealth Management Great Neck, New York $478M AUM 50.95% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank's CARL Position: Q2 2026 in Review

Deutsche Bank increased its Carlsmed (CARL) stake by 3.5% in Q2 2026, buying an estimated $3.66K and bringing the position to 10,180 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #3469.

Deutsche Bank first reported a position in CARL in Q4 2025 and has held it in 3 quarters since. The position peaked at $121K in Q4 2025. 74 funds tracked by Wall St. Rank hold CARL as of Q2 2026.

  • Deutsche Bank held 10,180 shares of Carlsmed worth $106K as of Q2 2026.
  • Deutsche Bank bought 348 Carlsmed shares in Q2 2026, an estimated $3.66K.
  • Carlsmed made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3469 holding.
  • Deutsche Bank first reported a position in Carlsmed in Q4 2025 and has held it in 3 quarters since.
  • Deutsche Bank's Carlsmed position peaked at $121K in Q4 2025.
  • 74 funds tracked by Wall St. Rank held Carlsmed as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.